Targeting interplay between KLF4 and PRMT5 in carcinogenesis
靶向 KLF4 和 PRMT5 在致癌作用中的相互作用
基本信息
- 批准号:9977693
- 负责人:
- 金额:$ 25.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-08 至 2021-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectApoptosisArginineBreast Cancer CellBreast Cancer TreatmentBreast Cancer therapyBreast CarcinogenesisCell divisionCellsChemicalsChemosensitizationDNA DamageDNA damage checkpointDataDevelopmentEnzymesExhibitsGKLF proteinGenetic TranscriptionGoalsHumanImpairmentLeadMalignant - descriptorMammary NeoplasmsMammary TumorigenesisMediatingMethylationMethyltransferaseModelingMolecularOncogenicPathologicPatientsPharmaceutical PreparationsPlayPost-Translational Protein ProcessingProtein MethylationProteinsRadiation therapyRadiosensitizationRegulationRoleTestingThe Cancer Genome AtlasTherapeuticTherapeutic InterventionTumor Cell InvasionXenograft procedurebasecancer stem cellcarcinogenesisclinically relevantgenome integrityin vivoinhibitor/antagonistmalignant breast neoplasmmouse modelnovelnovel strategiesprotein complexself-renewaltriple-negative invasive breast carcinomatumor initiationtumor progressiontumorigenesisubiquitin-protein ligase
项目摘要
Targeting the interplay between KLF4 and PRMT5 in carcinogenesis
The goal of this project is to determine the impact of interplay between KLF4 and PRMT5 in breast
carcinogenesis and anti-breast cancer therapy. Krüppel-like factor 4 (KLF4) is a critical regulator of cell
fate for cell division, apoptosis, and DNA damage, and plays an ambivalent role in tumorigenesis.
Over 70% of human primary mammary cancers exhibit cellular accumulation of KLF4, and the impact
of KLF4 on breast cancer formation has been recently indicated by the TCGA (The Cancer Genome
Atlas). The most recent studies by us and others have demonstrated an oncogenic role for KLF4 in
breast carcinogenesis. Nevertheless, how KLF4 is regulated and how its deregulation contributes to
breast carcinogenesis remains unknown. Results from our recent purification of the KLF4 protein
complex revealed that two critical enzymes, VHL and PRMT5, tightly interact with and regulate KLF4.
While the ubiquitin E3 ligase VHL/VBC catalyzes KLF4 for ubiquitylation followed by degradation, we
observed that methylation of KLF4 protein by PRMT5 (an arginine-based methyltransferase) results in
the stabilization of KLF4 and promotion of KLF4-mediated transcription. Unexpected elevation of KLF4
levels due to enhanced KLF4 methylation counteracts KLF4 ubiquitylation, which in turn triggers tumor
initiation and promotes tumor invasion. We further observed that deregulation of KLF4 methylation by
aberrant PRMT5 expression impairs DNA damage checkpoint function, which could induce malignant
transformation due to loss of genomic integrity. Thus, we ask if PRMT5 is a critical factor that
determines the oncogenic role for KLF4 in breast carcinogenesis, and if the PRMT5-KLF4 cascade
could be a novel target for breast cancer therapy. This proposal aims to determine the
pathophysiological role of KLF4 methylation by PRMT5 in mammary tumorigenesis, and to further
identify the clinical relevance of the KLF4-PRMT5 axis in breast cancer therapy. In this project, we
plan to test the hypothesis that deregulation of KLF4 by PRMT5 promotes tumorigenesis and tumor
invasion by pursuing the following specific aims: (1) to determine how methylation of KLF4 by PRMT5
regulates KLF4 protein stability and function; (2) to determine how the dysregulation of KLF4 by
PRMT5 affects the self-renewal of breast cancer stem cells and promotes tumorigenesis; and (3) to
determine the impact of deregulation of KLF4 by PRMT5 in breast tumor progression/invasion and
validate the therapeutic intervention of our newly developed KLF4 methylation inhibitor in breast
cancer treatment using murine models.
靶向KLF4和PRMT5在癌变中的相互作用
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Correction: SSRP1 Cooperates with PARP and XRCC1 to Facilitate Single-Strand DNA Break Repair by Chromatin Priming.
更正:SSRP1 与 PARP 和 XRCC1 配合,通过染色质引发促进单链 DNA 断裂修复。
- DOI:10.1158/0008-5472.can-17-2729
- 发表时间:2017
- 期刊:
- 影响因子:11.2
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yong Wan其他文献
Yong Wan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yong Wan', 18)}}的其他基金
Targeting posttranslational modifications of CD73 in TNBCs
针对 TNBC 中 CD73 的翻译后修饰
- 批准号:
10359179 - 财政年份:2021
- 资助金额:
$ 25.32万 - 项目类别:
Targeting posttranslational modifications of B7-H4 in carcinogenesis and therapy
靶向 B7-H4 的翻译后修饰在癌发生和治疗中的作用
- 批准号:
10361572 - 财政年份:2021
- 资助金额:
$ 25.32万 - 项目类别:
Targeting Posttranslational Modifications in Breast Carcinogenesis
靶向乳腺癌发生中的翻译后修饰
- 批准号:
10365966 - 财政年份:2021
- 资助金额:
$ 25.32万 - 项目类别:
Targeting posttranslational modifications of B7-H4 in carcinogenesis and therapy
靶向 B7-H4 的翻译后修饰在癌发生和治疗中的作用
- 批准号:
10523400 - 财政年份:2021
- 资助金额:
$ 25.32万 - 项目类别:
Targeting Posttranslational Modifications in Breast Carcinogenesis
靶向乳腺癌发生中的翻译后修饰
- 批准号:
10523396 - 财政年份:2021
- 资助金额:
$ 25.32万 - 项目类别:
Targeting posttranslational modifications of CD73 in TNBCs
针对 TNBC 中 CD73 的翻译后修饰
- 批准号:
10184613 - 财政年份:2021
- 资助金额:
$ 25.32万 - 项目类别:
Targeting posttranslational modifications of B7-H4 in carcinogenesis and therapy
靶向 B7-H4 的翻译后修饰在癌发生和治疗中的作用
- 批准号:
10181635 - 财政年份:2021
- 资助金额:
$ 25.32万 - 项目类别:
Interplay between ER and TGF-b in carcinogenesis
ER 和 TGF-b 在致癌过程中的相互作用
- 批准号:
10523253 - 财政年份:2021
- 资助金额:
$ 25.32万 - 项目类别:
Targeting posttranslational modifications of CD73 in TNBCs
针对 TNBC 中 CD73 的翻译后修饰
- 批准号:
10523388 - 财政年份:2021
- 资助金额:
$ 25.32万 - 项目类别:
Interplay between ER and TGF-b in carcinogenesis
ER 和 TGF-b 在致癌过程中的相互作用
- 批准号:
9655714 - 财政年份:2016
- 资助金额:
$ 25.32万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:
10585802 - 财政年份:2023
- 资助金额:
$ 25.32万 - 项目类别:
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
- 批准号:
10719415 - 财政年份:2023
- 资助金额:
$ 25.32万 - 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10605856 - 财政年份:2023
- 资助金额:
$ 25.32万 - 项目类别:
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
- 批准号:
23K08773 - 财政年份:2023
- 资助金额:
$ 25.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
- 批准号:
23K15866 - 财政年份:2023
- 资助金额:
$ 25.32万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10743485 - 财政年份:2023
- 资助金额:
$ 25.32万 - 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
- 批准号:
10749797 - 财政年份:2023
- 资助金额:
$ 25.32万 - 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
- 批准号:
22K09076 - 财政年份:2022
- 资助金额:
$ 25.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
- 批准号:
10583516 - 财政年份:2022
- 资助金额:
$ 25.32万 - 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
- 批准号:
RGPIN-2019-05371 - 财政年份:2022
- 资助金额:
$ 25.32万 - 项目类别:
Discovery Grants Program - Individual